SSRIs And Suicide To Be Discussed By Pediatric Advisory Cmte. In September
This article was originally published in The Pink Sheet Daily
Executive Summary
Joint session with Psychopharmacologic Advisory Committee will be new cross-center committee's first meeting.
You may also be interested in...
FDA Analysis Of Antidepressant Pediatric Suicidality Data To Be Reviewed Sept. 13-14
Joint meeting of Psychopharmacologic and newly formed Pediatric Advisory Committees will review analysis performed by expert group assembled by Columbia University. Future research needs in pediatric suicidality will also be addressed.
FDA Analysis Of Antidepressant Pediatric Suicidality Data To Be Reviewed Sept. 13-14
Joint meeting of Psychopharmacologic and newly formed Pediatric Advisory Committees will review analysis performed by expert group assembled by Columbia University. Future research needs in pediatric suicidality will also be addressed.
FDA Forms Pediatric Ethics Subcommittee
The advisory panel will address pediatric ethical issues and IRB referrals related to clinical investigations involving children. The subcommittee's preliminary recommendations will be presented to the new Pediatric Advisory Committee.